| Aug 16 |
Genmab Announces Changes to its Executive Committee
|
| Aug 12 |
Genmab A/S 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 12 |
Genmab A/S (GMAB) Q2 2024 Earnings Call Transcript
|
| Aug 8 |
Genmab reports 1H results
|
| Aug 8 |
Genmab Announces Financial Results for the First Half of 2024
|
| Aug 8 |
Genmab Updates 2024 Financial Guidance
|
| Aug 5 |
Genmab stock slides 7% as BioNTech ends acasunlimab collaboration
|
| Aug 5 |
BioNTech exits PD-L1 development with Genmab as Q2 revenues drop
|
| Aug 5 |
BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls
|
| Aug 5 |
Genmab Takes Full Control of Acasunlimab Development Program
|
